Clinical outcomes | No. studies | I 2 | No. subjects | UMD (95% CI) |
---|---|---|---|---|
VAS | ||||
  Glu vs. Pla | 3 | 83.4 | 89 vs. 89 | −1.44 (−3.01, 0.12) |
  Glu vs. NSAIDs | 2 | 0 | 106 vs. 110 | −0.90 (−1.67, −0.14)* |
  Dia vs. Pla | 2 | 0 | 103 vs. 98 | −2.23 (−2.82, −1.64)* |
  Dia vs. NSAIDs | 2 | 0 | 181 vs. 182 | 0.15 (−0.29, 0.59) |
Total WOMAC score change | ||||
  Glu vs. Pla | 6 | 0 | 437 vs. 423 | −2.49 (−4.14, −0.83)* |
 Actual score | ||||
  Glu vs. Pla | 2 | 79.8 | 73 vs. 76 | 5.67 (−11.26, 22.61) |
Pain WOMAC score change | Â | Â | Â | Â |
  Glu vs. Pla | 10 | 66.3 | 1,069 vs. 1,056 | −0.75 (−1.18, −0.32)* |
  Glu vs. NSAIDs | 2 | 85.5 | 425 vs. 423 | −0.07 (−1.5, 1.36) |
 Actual score | ||||
  Glu vs. Pla | 4 | 81 | 408 vs. 418 | 0.06 (−1.33, 1.45) |
Functional WOMAC score change | ||||
  Glu vs. Pla | 10 | 67.6 | 1,069 vs. 1,056 | −0.58 (−1.98, 0.81) |
  Glu vs. NSAIDs | 2 | 77.1 | 425 vs. 423 | −0.84 (−2.95, 4.63) |
 Actual score | ||||
  Glu vs. Pla | 4 | 90.5 | 408 vs. 418 | −4.78 (−5.96, −3.59)* |
  Dia vs. Pla | 2 | 0 | 110 vs. 110 | −7.72 (−18.83, 3.39) |
  Dia vs. NSAIDs | 2 | 92.9 | 189 vs. 185 | −6.64 (−10.50, −2.78)* |
Stiffness WOMAC score change | ||||
  Glu vs. Pla | 7 | 68.1 | 759 vs. 743 | −0.02 (−0.06, 0.03) |
 Actual score | ||||
  Glu vs. Pla | 3 | 31.5 | 390 vs. 389 | 0.09 (−0.38, 0.56) |
  Dia vs. Pla | 2 | 1 | 110 vs. 110 | −0.68 ( −1.20, −0.16)* |
Lequesne score scores change | ||||
  Glu vs. Pla | 2 | 87.7 | 207 vs. 205 | −1.03 (−1.34, −0.72) * |
  Dia vs. Pla | 2 | 0 | 340 vs. 337 | 0.002 (−0.704, 0.708) |
Joint space width | ||||
  Glu vs. Pla | 4 | 86.4 | 357 vs. 350 | 0.008 (−0.232, 0.248) |
All adverse events | RR (95% CI) | |||
  Glu vs. Pla | 16 | 7.3 | 1,366 vs. 1,365 | 1.12 (1.02, 1.23)* |
  Glu vs. NSAIDs | 5 | 81.9 | 631 vs. 632 | 0.53 (0.24, 1.20) |
  Dia vs. Pla | 4 | 76.6 | 275 vs. 278 | 5.58 ( 2.14, 14.59)* |
  Dia vs. NSAIDs | 2 | 97.6 | 181 vs. 182 | 1.59 ( 0.47, 5.44) |
GI adverse event | ||||
  Glu vs. Pla | 14 | 0 | 1,217 vs. 1,211 | 0.99 ( 0.82, 1.19) |
  Glu vs. NSAIDs | 5 | 74.3 | 631 vs. 632 | 0.51 ( 0.22, 1.20) |
  Dia vs. Pla | 6 | 94.9 | 937 vs. 701 | 2.00 ( 0.69, 5.74) |
  Dia vs. NSAIDs | 3 | 86.6 | 373 vs. 267 | 1.37 ( 0.89, 2.10) |